Dr Syafiq Asnawi is a Lecturer at Jeffrey Cheah School of Medicine and Health Sciences. He holds a Bachelor of Biotechnology (Hons) degree majoring in Medical Biotechnology from Monash University, Clayton Campus, Australia in 2012. He obtained his PhD in 2018 in Biomedical Science from Monash University (Malaysia). His PhD research was focusing on the proteomic characterization and anti-cancer activities from the venom of Malaysian pit vipers on human colon cancer cells.

Throughout his studies, Dr Syafiq acquired the skills and was trained in various advanced proteomic techniques such as operating and maintaining mass spectrometry system (Agilent QTOF LCMS and Agilent QQQ LCMS) and data analysis using various advanced proteomic software such as PEAKS (Bioinformatics Solutions Inc., Canada) and Spectrum Mill (Agilent). He was previously appointed as the Principal Technical Officer at the LCMS Platform, JCSMHS, Monash University Malaysia and was actively involved in managing and participating in workshops as a speaker and an LCMS content expert.

His major research grants include co-investigator in a Wellcome Trust UK funded project and principal investigator in a grant award from the Royal Society of Tropical Medicine and Hygiene-Wellcome Trust UK.

• Venomics – Snake venom and Jellyfish
• Anti-cancer Therapeutics
• Anti-venom Research
• Liquid Chromatography-Mass Spectrometry
• Proteomics and Metabolomics

• Biochemistry/Biomedical Science – MED1100 & MED1200
• Problem Based Learning – MED1100 & MED1200
• Student Project Cases (Discipline Co-coordinator) – MED 2100 & MED 2200
• Moodle Co-coordinator – MED 1100&1200 & MED 2100&2200

Please find the project information here:

1. https://supervisorconnect.med.monash.edu/projects/potential-antivenom-activity-malaysian-common-herbs-and-medicinal-plant-venom-malaysian
2. https://supervisorconnect.med.monash.edu/projects/proteomic-characterisation-venom-malaysian-venomous-jellyfish
3. https://supervisorconnect.med.monash.edu/projects/anticancer-activities-selected-snake-venom-proteins-human-cancer-cells